Join to view full profile
55 Fruit StPathology AssociatesBoston, MA 02114
Phone+1 617-726-2966
Fax+1 617-726-7533
Dr. Colvin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1969 - 1972- Massachusetts General HospitalInternship, Transitional Year, 1968 - 1969
Harvard Medical SchoolClass of 1968
Certifications & Licensure
MA State Medical License 1969 - 2027
NH State Medical License 2015 - 2021
American Board of Pathology Anatomic Pathology- American Board of Pathology Immunopathology
Publications & Presentations
PubMed
- 1 citationsAdvancing Hope Through Science: The Inaugural Richard Slayman International Workshop on Xenotransplantation.Leonardo V Riella, Joren C Madsen, Richard N Pierson 3rd, Thiago J Borges, David Sachs
Transplantation. 2026-09-01 - Pathologic evaluation of pig kidney and heart xenografts: 2024 recommendations from the Banff Xenotransplantation Pathology Working Group.Ivy A Rosales, Alton Brad Farris, Valentin Goutaudier, Aurelie Sannier, Huma Fatima
American Journal of Transplantation. 2026-07-01 - 1 citationsThe Banff 2024 Kidney Meeting Report: Rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning.Maarten Naesens, Candice Roufosse, Lynn D Cornell, Mark Haas, Roslyn B Mannon
American Journal of Transplantation. 2026-05-01
Journal Articles
- Case 34-2020: A 74-Year-Old Man with Chronic Kidney DiseaseEugene P Rhee, Rahul Sakhuja, Robert B Colvin, The New England Journal of Medicine
Press Mentions
CANbridge Forms Scientific Advisory Board to Guide Global Development of CAN106 in Complement-Mediated DiseasesJuly 6th, 2022- SeQure Dx Announces $17.5M Series A FundingAugust 3rd, 2021
- SeQure Dx Raises $17.5M in Series A FundingAugust 3rd, 2021
Grant Support
- Mechanisms Of Acceptance In Mouse Renal AllograftsNational Institute Of Allergy And Infectious Diseases2010–2012
- ImmunopathologyNational Heart, Lung, And Blood Institute2009–2012
- PathologyNational Institute Of Allergy And Infectious Diseases2010–2011
- Mechanisms Of Acceptance Of Mouse Renal AllograftsNational Institute Of Allergy And Infectious Diseases2009
- Core--PathologyNational Institute Of Allergy And Infectious Diseases2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
